Paul D. Uhlendorf - Concepedia

Author

Paul D. Uhlendorf

Gaertner (United States)

Also Known As

P D Uhlendorf, P Uhlendorf, P.D. Uhlendorf, Paul D. Uhlendorf, Paul Uhlendorf

Publications

611

Citations

H-Index

Concepts

All Affiliations

Gaertner (United States)Time Warner (United States)Warde Medical Laboratory

About

Paul D. Uhlendorf is an author at Gaertner (United States) specializing in medicine, physiology, and metabolism.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	583
2	Health Sciences	4	4	328
3	Biochemistry	3	3	156
4	Clinical Nutrition	1	1	25
5	Endocrinology	1	1	32

Paul D. Uhlendorf

Publications

609

Citations

H-Index

Page 1

	Year	Citations
Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological, and morphometric evaluation. Thomas Bocan, Sandra Bak Mueller, Paul D. Uhlendorf, Arteriosclerosis and Thrombosis A Journal of Vascular Biology Vascular DiseaseCardiovascular PharmacologyHyperlipidemiaOxidative StressInflammation	1991	157
The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation Thomas Bocan, Sandra Bak Mueller, Paul D. Uhlendorf, Atherosclerosis ObesityNutritionMetabolic SyndromeLipid DisorderBody Composition	1993	114
Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors Thomas Bocan, Erika Ferguson, W. McNally, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism Nonhepatic Sterol SynthesisHmg-coa Reductase InhibitorsHepatologyMedicineLiver Physiology	1992	86
Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation Thomas Bocan, Sandra Bak Mueller, Edie Quenby Brown, Atherosclerosis OxysterolBiochemistryMedicineAntiatherosclerotic ActivityCholesterol-fed Rabbits	1994	80
Antiatherosclerotic effects of antioxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand White rabbits Thomas Bocan, Sandra Bak Mueller, Edie Quenby Brown, Experimental and Molecular Pathology Antiatherosclerotic EffectsOxysterolCardiovascular DiseaseMedicineLipid Peroxidation	1992	45
Inhibition of acyl-CoA cholesterol O-acyltransferase reduces the cholesteryl ester enrichment of atherosclerotic lesions in the Yucatan micropig Thomas Bocan, Sandra Bak Mueller, Paul D. Uhlendorf, Atherosclerosis Acyl-coa Cholesterol O-acyltransferaseOxysterolCardiovascular DiseaseBiochemistryPhysiology	1993	44
Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats Richard E. Maxwell, J.W. Nawrocki, Paul D. Uhlendorf Atherosclerosis Animal PhysiologyMetabolic SyndromeOxysterolBiochemistryMedicine	1983	32
The Hypolipidæmic Effect of Gemfibrozil (CI-719) in Laboratory Animals Gertrude Rodney, Paul D. Uhlendorf, Richard E. Maxwell Proceedings of the Royal Society of Medicine OxysterolLipid PeroxidationPhysiologyHypolipidæmic EffectMetabolism	1976	26
Dietary and mechanically induced rabbit Iliac-femoral atherosclerotic lesions: A chemical and morphologic evaluation Thomas Bocan, Sandra Bak Mueller, Paul D. Uhlendorf, Experimental and Molecular Pathology NutritionBody CompositionPhysiologyClinical NutritionMorphologic Evaluation	1991	25

Page 1